Re: Re: MSH-Where can this product be bought!!!

[Guest guest]

I would be willing to travel almost anywhere for some relief of multiple symptoms from lack of MSH such as MRSE and Acropermatittis Chromium Atrophicians ACA(Rash seen in later Stage Lyme and Syphilis). Carol

In a message dated 6/17/06 6:33:09 AM Eastern Daylight Time, juancaqd@... writes:

http://www.zengen.com/technology.htm#infectiveCZEN 002 has been the focus of the Company's research into the control of infection. Microorganisms (e.g., fungi, bacteria, viruses) cause a host of symptoms by their occupation of vulnerable body sites, overgrowth, and interference with cell metabolism, all of which can give rise to a broad range of life-threatening diseases and disorders. CZEN 002 has been shown to directly kill pathological fungi, gram-negative and gram-positive bacteria and to inhibit replication of HIV-1, the virus responsible for AIDS.Therapeutic Peptide Portfolio Anti-Inflammatory Activity Anti-Infective Activity Competitive Advantages over Glucocorticoid Steroids Recent Patents Partnering & #945;-MSH, a molecule which occurs naturally in the body, modulates inflammatory and immune responses. Dr. Lipton, Zengen's President and CEO, first demonstrated that & #945;-MSH possesses anti-inflammatory properties and discovered the specific activity of the carboxy-terminal tripeptide region (C-terminal peptide) of the & #945;-MSH peptide. These discoveries led to the development of Zengen's proprietary peptide molecules, including the lead small-molecule CZEN 002. A synthetic octapeptide, CZEN 002 has broad application as an anti-inflammatory and anti-infective prescription pharmaceutical agent. Zengen and its European partner are currently conducting Phase IIb clinical trials with CZEN 002 in vaginal yeast infection, vulvovaginal candidiasis (VVC), and developing the molecule for treatment of inflammation.

[Guest guest]

Carol and other females,

Perhaps you could email Zengen or call them

and ask if you can get in their phase 2 b study for yeast infections, if you

have such. It might be the free cure of your illnesses.

a

In a message dated 6/17/06 6:33:09 AM Eastern Daylight Time,

juancaqd@... writes:

http://www.zengen.com/technology.htm#infective

CZEN 002 has been the focus of the Company's research into

the control

of infection. Microorganisms (e.g., fungi, bacteria, viruses) cause a

host of symptoms by their occupation of vulnerable body sites,

overgrowth, and interference with cell metabolism, all of which can

give rise to a broad range of life-threatening diseases and disorders.

CZEN 002 has been shown to directly kill pathological fungi, gram-

negative and gram-positive bacteria and to inhibit replication of HIV-

1, the virus responsible for AIDS.

Therapeutic Peptide Portfolio

Anti-Inflammatory Activity

Anti-Infective Activity

Competitive Advantages over Glucocorticoid Steroids

Recent Patents

Partnering

& #945;-MSH, a molecule which occurs naturally in the body, modulates

inflammatory and immune responses. Dr. Lipton, Zengen's

President and CEO, first demonstrated that & #945;-MSH possesses anti-

inflammatory properties and discovered the specific activity of the

carboxy-terminal tripeptide region (C-terminal peptide) of the & #945;-MSH

peptide. These discoveries led to the development of Zengen's

proprietary peptide molecules, including the lead small-molecule CZEN

002. A synthetic octapeptide, CZEN 002 has broad application as an

anti-inflammatory and anti-infective prescription pharmaceutical

agent. Zengen and its European partner are currently conducting Phase

IIb clinical trials with CZEN 002 in vaginal yeast infection,

vulvovaginal candidiasis (VVC), and developing the molecule for

treatment of inflammation.